a1 St John's Hospital, Stone, Aylesbury and the Institute of Psychiatry, London
Evidence from a controlled, comparative trial indicates that oral pimozide is clinically at least as effective as depot injections of fluphenazine decanoate in the continuation therapy of a group of schizophrenic patients discharged from hospital. The administration of pimozide was associated with fewer unwanted effects. The implications of the findings are discussed.
c1 Address for correspondence: Professor Michael Shepherd, Institute of Psychiatry, De Crespigny Park, London SE5 8AF.